Financial Statements Notes to the Financial Statements 31. SEGMENT REPORTING (continued) Hospital and Healthcare Singapore Malaysia India Greater China Türkiye and Europe Southeast Asia 2024 RM’mil RM’mil RM’mil RM’mil RM’mil RM’mil Revenue and expenses Revenue from external customers 6,131 4,154 4,028 1,529 7,238 – Inter-segment revenue 15 8 2 1 11 – Total segment revenue 6,146 4,162 4,030 1,530 7,249 – EBITDA 1,825 1,060 723 145 1,489 (2) Depreciation and impairment of property, plant and equipment (208) (248) (148) (103) (220) – Depreciation of ROU assets (334) (29) (25) (58) (80) – Amortisation of intangible assets – (1) (12) (2) (5) – Foreign exchange differences (1) 1 (14) 3 18 – Finance income 42 9 41 – 168 – Finance costs (177) (30) (103) (214) (645) – Net monetary gain arising from hyperinflationary economy – – – – – – Share of profits of associates (net of tax) 1 – 5 – – 20 Share of profits of joint ventures (net of tax) 1 1 1 – – – Others 239 – 15 – – – Profit/(loss) before tax 1,388 763 483 (229) 725 18 Income tax expense (218) (211) (104) (9) (122) – Profit/(loss) for the year 1,170 552 379 (238) 603 18 Assets and liabilities Cash and cash equivalents 63 148 748 116 180 – Other assets 20,580 11,220 6,020 2,939 6,258 54 Segment assets as at 31 December 2024 20,643 11,368 6,768 3,055 6,438 54 Loans and borrowings – 4,343 1,190 3,575 814 – Other liabilities 10,240 1,500 2,348 909 3,759 1 Segment liabilities as at 31 December 2024 10,240 5,843 3,538 4,484 4,573 1 * Includes loss on change in fair value of investment properties of RM32 million. IHH Healthcare Berhad | Annual Report 2024 186
RkJQdWJsaXNoZXIy NDgzMzc=